Picture of Resverlogix logo

RVX Resverlogix Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Resverlogix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
April 30th
2020
April 30th
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-163118-24.8-3.61-16.7
Depreciation
Non-Cash Items134-13611-5.6612.8
Unusual Items
Other Non-Cash Items
Changes in Working Capital-20.4-0.3284.644.720.613
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-48.8-17.3-8.02-3.54-2.61
Capital Expenditures-0.622-0.5-0.877-0.45-0.448
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.109-0.0760.044-0.023-0.068
Other Investing Cash Flow
Cash from Investing Activities-0.731-0.576-0.833-0.473-0.516
Financing Cash Flow Items-4.56-2.27-0.419-0.0853.22
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities57.110.28.814.063.09
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash7.57-7.68-0.0810.034-0.035